desvenlafaxine succinate ER
Marketedupdated 2mo agoby Intellipharmaceutics Ltd
Approvedcommunity read0 votes
indications
investigational
Major Depression
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
no news has mentioned this drug yet
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
comments(0)
5-min edit window · permanent after that